MedPath

Pulmonary Hypertension and Chronic Kidney disease

Not Applicable
Conditions
Health Condition 1: N181- Chronic kidney disease, stage 1Health Condition 2: N182- Chronic kidney disease, stage 2 (mild)Health Condition 3: N183- Chronic kidney disease, stage 3 (moderate)Health Condition 4: N184- Chronic kidney disease, stage 4 (severe)Health Condition 5: N185- Chronic kidney disease, stage 5Health Condition 6: N189- Chronic kidney disease, unspecifiedHealth Condition 7: N186- End stage renal disease
Registration Number
CTRI/2024/05/067547
Lead Sponsor
ikhil Pantbalekundri
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Newly Diagnosed CKD cases

2) Known cases of CKD on Conservative treatment

3) Known case of CKD on maintenance hemodialysis

4) Patients giving consent

Exclusion Criteria

1) Not willing to Participate

2) Age less than 18years

3) Valvular heart disease

4) Congenital heart Disease

5) Pulmonary obstructive and restrictive diseases

6) HIV infected patients

7) Chronic liver disease

8) Connective tissue diseases

9) Hypothyroidism and Hyperthyroidism

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Statistically significant (p0.05) Prevalence of Pulmonary artery hypertension in patients of Chronic kidney disease (PASP 35 mmHg) <br/ ><br>2) Prevalence is higher with higher grades of chronic kidney disease <br/ ><br>2) Pulmonary artery hypertension can be used as an indicator for poor prognosis in end stage renal diseaseTimepoint: 2 years
Secondary Outcome Measures
NameTimeMethod
strong association between diabetes & hypertension with PH (p less than 0.001)Timepoint: 8 days after admission
© Copyright 2025. All Rights Reserved by MedPath